Amsterdam, The Netherlands; and Gold Coast, Queensland, Australia
From the Department of Surgery, Amsterdam Gastroenterology and Metabolism, Amsterdam UMC location AMC, University of Amsterdam; and Menzies Health Institute Queensland and School of Nursing and Midwifery, Griffith University.
Disclosure: Dr. Zwanenburg is a speaker for GD Medical. Dr. Boermeester reports institutional grants from Johnson & Johnson /Ethicon, 3M/KCI, Allergan/LifeCell, Ipsen, Mylan, and New Compliance; is an advisory board member of Johnson & Johnson/Ethicon, KCI/3M, and Bard/BD; and is speaker and/or instructor for 3M/KCI, Allergan/LifeCell, Bard/BD, Johnson & Johnson/Ethicon, Gore, GD Medical, and Smith & Nephew. The remaining authors have no financial interests to declare. No funding was received in support of this study.
Received for publication November 19, 2021; accepted August 18, 2021.
This study is registered under the name “Comparing negative pressure wound therapy with instillation (NPWT-I) with other types of wound care for the treatment of infected and contaminated wounds,” PROSPERO identification no. CRD42020167226 (https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020167226).
Related digital media are available in the full-text version of the article on www.PRSJournal.com.
Marja A. Boermeester, M.D., Ph.D., M.Sc., Department of Surgery, Suite J1A-228, Amsterdam Gastroenterology and Metabolism, Amsterdam Infection & Immunity, Amsterdam UMC, location AMC, Meibergdreef 9, 1100 DD Amsterdam, The Netherlands, [email protected]